ID   DHB4_HUMAN              Reviewed;         736 AA.
AC   P51659; B4DNV1; B4DVS5; E9PB82; F5HE57;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Peroxisomal multifunctional enzyme type 2;
DE            Short=MFE-2;
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase 4;
DE            Short=17-beta-HSD 4;
DE   AltName: Full=D-bifunctional protein;
DE            Short=DBP;
DE   AltName: Full=Multifunctional protein 2;
DE            Short=MPF-2;
DE   AltName: Full=Short chain dehydrogenase/reductase family 8C member 1;
DE   Contains:
DE     RecName: Full=(3R)-hydroxyacyl-CoA dehydrogenase;
DE              EC=1.1.1.n12;
DE   Contains:
DE     RecName: Full=Enoyl-CoA hydratase 2;
DE              EC=4.2.1.107;
DE              EC=4.2.1.119;
DE     AltName: Full=3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase;
GN   Name=HSD17B4; Synonyms=EDH17B4, SDR8C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7487879; DOI=10.1042/bj3110437;
RA   Adamski J., Normand T., Leenders F., Monte D., Begue A., Stehelin D.,
RA   Jungblut P.W., de Launoit Y.;
RT   "Molecular cloning of a novel widely expressed human 80 kDa 17 beta-
RT   hydroxysteroid dehydrogenase IV.";
RL   Biochem. J. 311:437-443(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 69-77;
RP   81-90; 261-270; 291-310; 312-339; 413-426; 451-459; 478-488 AND
RP   590-631, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=9089413; DOI=10.1093/oxfordjournals.jbchem.a021596;
RA   Jiang L.L., Miyazawa S., Souri M., Hashimoto T.;
RT   "Structure of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA
RT   dehydrogenase bifunctional protein.";
RL   J. Biochem. 121:364-369(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9880674; DOI=10.1007/s003359900921;
RA   Leenders F., Dolez V., Begue A., Moller G., Gloeckner J.C.,
RA   de Launoit Y., Adamski J.;
RT   "Structure of the gene for the human 17beta-hydroxysteroid
RT   dehydrogenase type IV.";
RL   Mamm. Genome 9:1036-1041(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS HIS-106 AND VAL-559.
RC   TISSUE=Lung, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=8902629; DOI=10.1093/oxfordjournals.jbchem.a021458;
RA   Jiang L.L., Kobayashi A., Matsuura H., Fukushima H., Hashimoto T.;
RT   "Purification and properties of human D-3-hydroxyacyl-CoA dehydratase:
RT   medium-chain enoyl-CoA hydratase is D-3-hydroxyacyl-CoA dehydratase.";
RL   J. Biochem. 120:624-632(1996).
RN   [8]
RP   MUTAGENESIS OF TYR-347; GLU-366; ASP-370; HIS-406; GLU-408; TYR-410;
RP   ASP-490; TYR-505; ASP-510; HIS-515; ASP-517 AND HIS-532, AND
RP   CHARACTERIZATION OF VARIANT DBPD SER-16.
RX   PubMed=10671535; DOI=10.1074/jbc.275.7.4965;
RA   Qin Y.M., Haapalainen A.M., Kilpelainen S.H., Marttila M.S.,
RA   Koski M.K., Glumoff T., Novikov D.K., Hiltunen J.K.;
RT   "Human peroxisomal multifunctional enzyme type 2. Site-directed
RT   mutagenesis studies show the importance of two protic residues for 2-
RT   enoyl-CoA hydratase 2 activity.";
RL   J. Biol. Chem. 275:4965-4972(2000).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304 AND SER-309, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-565; LYS-669 AND LYS-707,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-265, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 618-736 IN COMPLEX WITH
RP   LIGAND.
RX   PubMed=11700068; DOI=10.1006/jmbi.2001.5084;
RA   Haapalainen A.M., van Aalten D.M., Merilaeinen G., Jalonen J.E.,
RA   Pirilae P., Wierenga R.K., Hiltunen J.K., Glumoff T.;
RT   "Crystal structure of the liganded SCP-2-like domain of human
RT   peroxisomal multifunctional enzyme type 2 at 1.75 A resolution.";
RL   J. Mol. Biol. 313:1127-1138(2001).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 320-614.
RX   PubMed=15644212; DOI=10.1016/j.jmb.2004.11.009;
RA   Koski K.M., Haapalainen A.M., Hiltunen J.K., Glumoff T.;
RT   "Crystal structure of 2-enoyl-CoA hydratase 2 from human peroxisomal
RT   multifunctional enzyme type 2.";
RL   J. Mol. Biol. 345:1157-1169(2005).
RN   [18]
RP   VARIANT DBPD SER-16.
RX   PubMed=9482850; DOI=10.1073/pnas.95.5.2128;
RA   van Grunsven E.G., van Berkel E., Ijlst L., Vreken P.,
RA   de Klerk J.B.C., Adamski J., Lemonde H., Clayton P.T., Cuebas D.A.,
RA   Wanders R.J.A.;
RT   "Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of
RT   the enzyme defect and its molecular basis in bifunctional protein
RT   deficiency.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2128-2133(1998).
RN   [19]
RP   VARIANT DBPD TYR-457, AND VARIANT ARG-511.
RX   PubMed=10400999; DOI=10.1093/hmg/8.8.1509;
RA   van Grunsven E.G., Mooijer P.A., Aubourg P., Wanders R.J.;
RT   "Enoyl-CoA hydratase deficiency: identification of a new type of D-
RT   bifunctional protein deficiency.";
RL   Hum. Mol. Genet. 8:1509-1516(1999).
RN   [20]
RP   VARIANT DBPD PRO-106.
RX   PubMed=11743515; DOI=10.1067/mpd.2001.119170;
RA   Nakano K., Zhang Z., Shimozawa N., Kondo N., Ishii N., Funatsuka M.,
RA   Shirakawa S., Itoh M., Takashima S., Une M., Kana-aki R.R., Mukai K.,
RA   Osawa M., Suzuki Y.;
RT   "D-bifunctional protein deficiency with fetal ascites, polyhydramnios,
RT   and contractures of hands and toes.";
RL   J. Pediatr. 139:865-867(2001).
RN   [21]
RP   VARIANT PRLTS1 CYS-217.
RX   PubMed=20673864; DOI=10.1016/j.ajhg.2010.07.007;
RA   Pierce S.B., Walsh T., Chisholm K.M., Lee M.K., Thornton A.M.,
RA   Fiumara A., Opitz J.M., Levy-Lahad E., Klevit R.E., King M.C.;
RT   "Mutations in the DBP-deficiency protein HSD17B4 cause ovarian
RT   dysgenesis, hearing loss, and ataxia of Perrault Syndrome.";
RL   Am. J. Hum. Genet. 87:282-288(2010).
RN   [22]
RP   VARIANTS HIS-106 AND VAL-559.
RX   PubMed=25956234; DOI=10.1016/j.jns.2015.04.038;
RA   Ahmed S., Jelani M., Alrayes N., Mohamoud H.S., Almramhi M.M.,
RA   Anshasi W., Ahmed N.A., Wang J., Nasir J., Al-Aama J.Y.;
RT   "Exome analysis identified a novel missense mutation in the CLPP gene
RT   in a consanguineous Saudi family expanding the clinical spectrum of
RT   Perrault Syndrome type-3.";
RL   J. Neurol. Sci. 353:149-154(2015).
CC   -!- FUNCTION: Bifunctional enzyme acting on the peroxisomal beta-
CC       oxidation pathway for fatty acids. Catalyzes the formation of 3-
CC       ketoacyl-CoA intermediates from both straight-chain and 2-methyl-
CC       branched-chain fatty acids. {ECO:0000269|PubMed:8902629,
CC       ECO:0000269|PubMed:9089413}.
CC   -!- CATALYTIC ACTIVITY: (R)-3-hydroxyacyl-CoA + NAD(+) = 3-oxoacyl-CoA
CC       + NADH. {ECO:0000269|PubMed:9089413}.
CC   -!- CATALYTIC ACTIVITY: (24R,25R)-3-alpha,7-alpha,12-alpha,24-
CC       tetrahydroxy-5-beta-cholestanoyl-CoA = (24E)-3-alpha,7-alpha,12-
CC       alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA + H(2)O.
CC       {ECO:0000269|PubMed:9089413}.
CC   -!- CATALYTIC ACTIVITY: (3R)-3-hydroxyacyl-CoA = (2E)-2-enoyl-CoA +
CC       H(2)O. {ECO:0000269|PubMed:9089413}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10 uM for D-3-hydroxy-octanoyl-CoA
CC         {ECO:0000269|PubMed:9089413};
CC         KM=13 uM for NAD {ECO:0000269|PubMed:9089413};
CC         KM=2.7 uM for 3-ketooctanoyl-CoA {ECO:0000269|PubMed:9089413};
CC         KM=5.4 uM for NADH {ECO:0000269|PubMed:9089413};
CC         Vmax=8.8 umol/min/mg enzyme {ECO:0000269|PubMed:9089413};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11700068,
CC       ECO:0000269|PubMed:8902629}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51659-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51659-2; Sequence=VSP_046152;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P51659-3; Sequence=VSP_046153;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Present in many tissues with highest
CC       concentrations in liver, heart, prostate and testis.
CC   -!- DISEASE: D-bifunctional protein deficiency (DBPD) [MIM:261515]:
CC       Disorder of peroxisomal fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:10400999, ECO:0000269|PubMed:10671535,
CC       ECO:0000269|PubMed:11743515, ECO:0000269|PubMed:9482850}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Perrault syndrome 1 (PRLTS1) [MIM:233400]: A sex-
CC       influenced disorder characterized by sensorineural deafness in
CC       both males and females and ovarian dysgenesis in females. Some
CC       patients also have neurologic manifestations, including mild
CC       mental retardation and cerebellar and peripheral nervous system
CC       involvement. {ECO:0000269|PubMed:20673864}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The protein is found both as a full length peptide
CC       and in a cleaved version.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X87176; CAA60643.1; -; mRNA.
DR   EMBL; AF057740; AAD08652.1; -; Genomic_DNA.
DR   EMBL; AF057720; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057721; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057722; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057723; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057724; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057725; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057726; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057727; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057728; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057729; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057730; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057731; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057732; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057733; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057734; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057735; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057736; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057737; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057738; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AF057739; AAD08652.1; JOINED; Genomic_DNA.
DR   EMBL; AK298075; BAG60363.1; -; mRNA.
DR   EMBL; AK301212; BAG62787.1; -; mRNA.
DR   EMBL; AC024564; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003098; AAH03098.1; -; mRNA.
DR   CCDS; CCDS4126.1; -. [P51659-1]
DR   CCDS; CCDS56378.1; -. [P51659-3]
DR   CCDS; CCDS56379.1; -. [P51659-2]
DR   PIR; S59136; S59136.
DR   RefSeq; NP_000405.1; NM_000414.3. [P51659-1]
DR   RefSeq; NP_001186220.1; NM_001199291.2. [P51659-2]
DR   RefSeq; NP_001186221.1; NM_001199292.1. [P51659-3]
DR   RefSeq; NP_001278956.1; NM_001292027.1.
DR   RefSeq; NP_001278957.1; NM_001292028.1.
DR   UniGene; Hs.406861; -.
DR   PDB; 1IKT; X-ray; 1.75 A; A=618-736.
DR   PDB; 1S9C; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L=318-615.
DR   PDB; 1ZBQ; X-ray; 2.71 A; A/B/C/D/E/F=1-304.
DR   PDBsum; 1IKT; -.
DR   PDBsum; 1S9C; -.
DR   PDBsum; 1ZBQ; -.
DR   ProteinModelPortal; P51659; -.
DR   SMR; P51659; -.
DR   BioGrid; 109528; 41.
DR   IntAct; P51659; 31.
DR   MINT; MINT-1135639; -.
DR   STRING; 9606.ENSP00000420914; -.
DR   ChEMBL; CHEMBL5814; -.
DR   DrugBank; DB03192; 3r-Hydroxydecanoyl-Coa.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000000540; -.
DR   iPTMnet; P51659; -.
DR   PhosphoSitePlus; P51659; -.
DR   SwissPalm; P51659; -.
DR   BioMuta; HSD17B4; -.
DR   DMDM; 1706396; -.
DR   EPD; P51659; -.
DR   MaxQB; P51659; -.
DR   PaxDb; P51659; -.
DR   PeptideAtlas; P51659; -.
DR   PRIDE; P51659; -.
DR   TopDownProteomics; P51659-1; -. [P51659-1]
DR   DNASU; 3295; -.
DR   Ensembl; ENST00000256216; ENSP00000256216; ENSG00000133835. [P51659-1]
DR   Ensembl; ENST00000504811; ENSP00000420914; ENSG00000133835. [P51659-2]
DR   Ensembl; ENST00000515320; ENSP00000424613; ENSG00000133835. [P51659-3]
DR   GeneID; 3295; -.
DR   KEGG; hsa:3295; -.
DR   UCSC; uc003ksj.4; human. [P51659-1]
DR   CTD; 3295; -.
DR   DisGeNET; 3295; -.
DR   GeneCards; HSD17B4; -.
DR   H-InvDB; HIX0078166; -.
DR   HGNC; HGNC:5213; HSD17B4.
DR   HPA; HPA021302; -.
DR   HPA; HPA021311; -.
DR   HPA; HPA021479; -.
DR   MalaCards; HSD17B4; -.
DR   MIM; 233400; phenotype.
DR   MIM; 261515; phenotype.
DR   MIM; 601860; gene.
DR   neXtProt; NX_P51659; -.
DR   OpenTargets; ENSG00000133835; -.
DR   Orphanet; 300; Bifunctional enzyme deficiency.
DR   Orphanet; 2855; Perrault syndrome.
DR   PharmGKB; PA29481; -.
DR   eggNOG; KOG1206; Eukaryota.
DR   eggNOG; COG2030; LUCA.
DR   GeneTree; ENSGT00530000062928; -.
DR   HOGENOM; HOG000170895; -.
DR   HOVERGEN; HBG002174; -.
DR   InParanoid; P51659; -.
DR   KO; K12405; -.
DR   OMA; TVMPEDL; -.
DR   OrthoDB; EOG091G02S9; -.
DR   PhylomeDB; P51659; -.
DR   TreeFam; TF105656; -.
DR   BioCyc; MetaCyc:HS05792-MONOMER; -.
DR   BRENDA; 4.2.1.119; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-389887; Beta-oxidation of pristanoyl-CoA.
DR   Reactome; R-HSA-390247; Beta-oxidation of very long chain fatty acids.
DR   SABIO-RK; P51659; -.
DR   UniPathway; UPA00659; -.
DR   ChiTaRS; HSD17B4; human.
DR   EvolutionaryTrace; P51659; -.
DR   GeneWiki; HSD17B4; -.
DR   GenomeRNAi; 3295; -.
DR   PRO; PR:P51659; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000133835; -.
DR   CleanEx; HS_HSD17B4; -.
DR   ExpressionAtlas; P51659; baseline and differential.
DR   Genevisible; P51659; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0044594; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0033989; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; TAS:Reactome.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016508; F:long-chain-enoyl-CoA hydratase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0008209; P:androgen metabolic process; IDA:UniProtKB.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0008210; P:estrogen metabolic process; IDA:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome.
DR   GO; GO:0036112; P:medium-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0060009; P:Sertoli cell development; IEA:Ensembl.
DR   GO; GO:0000038; P:very long-chain fatty acid metabolic process; IEA:Ensembl.
DR   GO; GO:0036111; P:very long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.30.1050.10; -; 1.
DR   InterPro; IPR029069; HotDog_dom.
DR   InterPro; IPR002539; MaoC_dom.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR003033; SCP2_sterol-bd_dom.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   Pfam; PF01575; MaoC_dehydratas; 1.
DR   Pfam; PF02036; SCP2; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF54637; SSF54637; 2.
DR   SUPFAM; SSF55718; SSF55718; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Deafness; Direct protein sequencing; Disease mutation;
KW   Fatty acid metabolism; Isomerase; Lipid metabolism; Lyase; NAD;
KW   Oxidoreductase; Peroxisome; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    736       Peroxisomal multifunctional enzyme type
FT                                2.
FT                                /FTId=PRO_0000054583.
FT   CHAIN         1    311       (3R)-hydroxyacyl-CoA dehydrogenase.
FT                                /FTId=PRO_0000400082.
FT   CHAIN       312    736       Enoyl-CoA hydratase 2.
FT                                /FTId=PRO_0000400083.
FT   DOMAIN      484    600       MaoC-like.
FT   DOMAIN      624    736       SCP2.
FT   NP_BIND      13     37       NAD. {ECO:0000250}.
FT   NP_BIND      75     76       NAD.
FT   NP_BIND     164    168       NAD.
FT   NP_BIND     196    199       NAD.
FT   REGION        1    305       (3R)-hydroxyacyl-CoA dehydrogenase.
FT   REGION      322    622       Enoyl-CoA hydratase 2.
FT   REGION      406    407       (3R)-3-hydroxydecanoyl-CoA binding.
FT                                {ECO:0000250}.
FT   REGION      510    515       (3R)-3-hydroxydecanoyl-CoA binding.
FT                                {ECO:0000250}.
FT   MOTIF       734    736       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    164    164       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING      21     21       NAD; via amide nitrogen.
FT   BINDING      40     40       NAD.
FT   BINDING      99     99       NAD; via carbonyl oxygen.
FT   BINDING     151    151       Substrate. {ECO:0000250}.
FT   BINDING     435    435       (3R)-3-hydroxydecanoyl-CoA.
FT                                {ECO:0000250}.
FT   BINDING     533    533       (3R)-3-hydroxydecanoyl-CoA; via amide
FT                                nitrogen. {ECO:0000250}.
FT   BINDING     563    563       (3R)-3-hydroxydecanoyl-CoA; via carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     706    706       Substrate.
FT   BINDING     724    724       Substrate.
FT   MOD_RES      46     46       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES      46     46       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      57     57       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES      68     68       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES      84     84       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     265    265       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     275    275       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     309    309       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     356    356       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     424    424       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     565    565       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     579    579       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     663    663       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   MOD_RES     669    669       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     707    707       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     725    725       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P51660}.
FT   VAR_SEQ       1     38       MGSPLRFDGRVVLVTGAGAGLGRAYALAFAERGALVVV ->
FT                                MVILEAPHLLRRKEPETPGLSSRIGPSLCPGFCRKRSVSCC
FT                                FQNLCNNPMEKIISQCRFFVSM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046152.
FT   VAR_SEQ      20     37       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046153.
FT   VARIANT      16     16       G -> S (in DBPD; no dehydrogenase
FT                                activity; dbSNP:rs137853096).
FT                                {ECO:0000269|PubMed:10671535,
FT                                ECO:0000269|PubMed:9482850}.
FT                                /FTId=VAR_037576.
FT   VARIANT      90     90       F -> L (in dbSNP:rs28943588).
FT                                /FTId=VAR_052309.
FT   VARIANT     106    106       R -> H (in dbSNP:rs25640).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:25956234}.
FT                                /FTId=VAR_014872.
FT   VARIANT     106    106       R -> P (in DBPD; dbSNP:rs25640).
FT                                {ECO:0000269|PubMed:11743515}.
FT                                /FTId=VAR_065906.
FT   VARIANT     140    140       K -> N (in dbSNP:rs28943589).
FT                                /FTId=VAR_052310.
FT   VARIANT     217    217       Y -> C (in PRLTS1; dbSNP:rs387906825).
FT                                {ECO:0000269|PubMed:20673864}.
FT                                /FTId=VAR_065907.
FT   VARIANT     292    292       T -> S (in dbSNP:rs1143650).
FT                                /FTId=VAR_024625.
FT   VARIANT     427    427       A -> V (in dbSNP:rs28943590).
FT                                /FTId=VAR_052311.
FT   VARIANT     457    457       N -> Y (in DBPD; the mutation leads to an
FT                                unstable protein; dbSNP:rs137853097).
FT                                {ECO:0000269|PubMed:10400999}.
FT                                /FTId=VAR_065908.
FT   VARIANT     491    491       A -> T (in dbSNP:rs28943591).
FT                                /FTId=VAR_052312.
FT   VARIANT     511    511       W -> R (in dbSNP:rs11539471).
FT                                {ECO:0000269|PubMed:10400999}.
FT                                /FTId=VAR_014873.
FT   VARIANT     559    559       I -> V (in dbSNP:rs11205).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:25956234}.
FT                                /FTId=VAR_014874.
FT   VARIANT     606    606       A -> S (in dbSNP:rs15228).
FT                                /FTId=VAR_052313.
FT   VARIANT     687    687       T -> I (in dbSNP:rs28943592).
FT                                /FTId=VAR_052314.
FT   VARIANT     728    728       M -> V (in dbSNP:rs28943594).
FT                                /FTId=VAR_052315.
FT   MUTAGEN     347    347       Y->A: No hydratase activity.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     366    366       E->A: No hydratase activity.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     370    370       D->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     406    406       H->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     408    408       E->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     410    410       Y->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     490    490       D->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     505    505       Y->A: Completely inactive.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     510    510       D->A: No hydratase activity.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     515    515       H->A: Completely inactive.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     517    517       D->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   MUTAGEN     532    532       H->A: No effect.
FT                                {ECO:0000269|PubMed:10671535}.
FT   CONFLICT    587    587       Q -> R (in Ref. 4; BAG60363).
FT                                {ECO:0000305}.
FT   STRAND       11     14       {ECO:0000244|PDB:1ZBQ}.
FT   TURN         15     18       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX        20     31       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND       35     39       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX        53     64       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND       68     72       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX        76     78       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX        79     90       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND       95     98       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       108    110       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       113    141       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND      144    149       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       152    156       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       162    182       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       183    185       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND      187    194       {ECO:0000244|PDB:1ZBQ}.
FT   TURN        199    204       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       207    212       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       215    217       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       219    225       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND      236    240       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND      243    251       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       266    271       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       273    277       {ECO:0000244|PDB:1ZBQ}.
FT   HELIX       288    303       {ECO:0000244|PDB:1ZBQ}.
FT   STRAND      335    339       {ECO:0000244|PDB:1S9C}.
FT   HELIX       341    350       {ECO:0000244|PDB:1S9C}.
FT   HELIX       358    360       {ECO:0000244|PDB:1S9C}.
FT   HELIX       361    364       {ECO:0000244|PDB:1S9C}.
FT   HELIX       375    377       {ECO:0000244|PDB:1S9C}.
FT   HELIX       378    381       {ECO:0000244|PDB:1S9C}.
FT   HELIX       383    385       {ECO:0000244|PDB:1S9C}.
FT   HELIX       401    403       {ECO:0000244|PDB:1S9C}.
FT   STRAND      405    415       {ECO:0000244|PDB:1S9C}.
FT   STRAND      419    432       {ECO:0000244|PDB:1S9C}.
FT   STRAND      440    462       {ECO:0000244|PDB:1S9C}.
FT   STRAND      490    496       {ECO:0000244|PDB:1S9C}.
FT   HELIX       501    505       {ECO:0000244|PDB:1S9C}.
FT   HELIX       506    508       {ECO:0000244|PDB:1S9C}.
FT   HELIX       513    515       {ECO:0000244|PDB:1S9C}.
FT   HELIX       518    522       {ECO:0000244|PDB:1S9C}.
FT   TURN        523    525       {ECO:0000244|PDB:1S9C}.
FT   HELIX       533    548       {ECO:0000244|PDB:1S9C}.
FT   HELIX       553    555       {ECO:0000244|PDB:1S9C}.
FT   STRAND      556    563       {ECO:0000244|PDB:1S9C}.
FT   STRAND      572    580       {ECO:0000244|PDB:1S9C}.
FT   STRAND      583    590       {ECO:0000244|PDB:1S9C}.
FT   TURN        591    593       {ECO:0000244|PDB:1S9C}.
FT   STRAND      596    605       {ECO:0000244|PDB:1S9C}.
FT   HELIX       624    646       {ECO:0000244|PDB:1IKT}.
FT   STRAND      648    670       {ECO:0000244|PDB:1IKT}.
FT   STRAND      674    679       {ECO:0000244|PDB:1IKT}.
FT   STRAND      685    691       {ECO:0000244|PDB:1IKT}.
FT   HELIX       692    699       {ECO:0000244|PDB:1IKT}.
FT   HELIX       705    710       {ECO:0000244|PDB:1IKT}.
FT   STRAND      713    719       {ECO:0000244|PDB:1IKT}.
FT   HELIX       720    733       {ECO:0000244|PDB:1IKT}.
SQ   SEQUENCE   736 AA;  79686 MW;  7B11E02483328BCE CRC64;
     MGSPLRFDGR VVLVTGAGAG LGRAYALAFA ERGALVVVND LGGDFKGVGK GSLAADKVVE
     EIRRRGGKAV ANYDSVEEGE KVVKTALDAF GRIDVVVNNA GILRDRSFAR ISDEDWDIIH
     RVHLRGSFQV TRAAWEHMKK QKYGRIIMTS SASGIYGNFG QANYSAAKLG LLGLANSLAI
     EGRKSNIHCN TIAPNAGSRM TQTVMPEDLV EALKPEYVAP LVLWLCHESC EENGGLFEVG
     AGWIGKLRWE RTLGAIVRQK NHPMTPEAVK ANWKKICDFE NASKPQSIQE STGSIIEVLS
     KIDSEGGVSA NHTSRATSTA TSGFAGAIGQ KLPPFSYAYT ELEAIMYALG VGASIKDPKD
     LKFIYEGSSD FSCLPTFGVI IGQKSMMGGG LAEIPGLSIN FAKVLHGEQY LELYKPLPRA
     GKLKCEAVVA DVLDKGSGVV IIMDVYSYSE KELICHNQFS LFLVGSGGFG GKRTSDKVKV
     AVAIPNRPPD AVLTDTTSLN QAALYRLSGD WNPLHIDPNF ASLAGFDKPI LHGLCTFGFS
     ARRVLQQFAD NDVSRFKAIK ARFAKPVYPG QTLQTEMWKE GNRIHFQTKV QETGDIVISN
     AYVDLAPTSG TSAKTPSEGG KLQSTFVFEE IGRRLKDIGP EVVKKVNAVF EWHITKGGNI
     GAKWTIDLKS GSGKVYQGPA KGAADTTIIL SDEDFMEVVL GKLDPQKAFF SGRLKARGNI
     MLSQKLQMIL KDYAKL
//
